Thomas Numnum, MD
Gynecologic Oncology · Nashville, TNNPI 1346270014
Payments from drug & device makers
Across 332 payments — averaging $24.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1K
- GSK$1K
- AbbVie$690
- AstraZeneca$665
- Myriad Genetic Laboratories, Inc.$543
- Eisai Inc.$502
- plus $3K from 30 others
What the payments were for
- Food & beverage$7,84698%
- Education$1232%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 62 | $1,428 |
| GSK | 53 | $1,232 |
| AbbVie | 27 | $690 |
| AstraZeneca | 32 | $665 |
| Myriad Genetic Laboratories, Inc. | 19 | $543 |
| Eisai Inc. | 21 | $502 |
| Clovis Oncology, Inc. | 16 | $316 |
| Tempus AI, Inc | 8 | $253 |
| Astellas Pharma US Inc | 5 | $252 |
| Amgen | 13 | $242 |
| Immunogen, Inc. | 8 | $195 |
| Tesaro, Inc. | 6 | $164 |
| Seagen Inc. | 8 | $162 |
| Daiichi Sankyo Inc. | 6 | $153 |
| Baxter Healthcare | 4 | $141 |
| Pfizer | 4 | $101 |
| Stryker | 2 | $95 |
| Kyowa Kirin, Inc. | 6 | $95 |
| Cumberland Pharmaceuticals, Inc. | 3 | $72 |
| Aspira Women's Health Inc | 1 | $69 |
| Coherus Oncology, Inc. | 3 | $64 |
| Caris MPI, Inc. | 2 | $63 |
| Hologic Sales And Service, LLC | 2 | $61 |
| Dilon Technologies, Inc. | 2 | $51 |
| Mylan Institutional Inc. | 3 | $50 |
| Stemline Therapeutics Inc. | 2 | $50 |
| Coopersurgical, Inc. | 3 | $47 |
| Medtronic | 2 | $47 |
| Verastem, Inc. | 1 | $35 |
| Genentech USA, Inc. | 2 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| LSI Solutions Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $15 |
| Olympus America Inc. | 1 | $15 |
| Solventum Corporation | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,968 in reported general payments places this provider in the 55th percentile of 40 gynecologic oncology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 39 | $777 |
| Megestrol Acetate | 12 | $549 |
| Ondansetron Hcl | 27 | $320 |
| Estradiol | 12 | $241 |
| Clobetasol Propionate | 13 | $192 |
| Prochlorperazine Maleate | 11 | $168 |
| Fluconazole | 29 | $141 |
| Medroxyprogesterone Acetate | 12 | $92 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Nashville
- Marta CrispensNashville$1.5M
- Michael StanyNashville$347K
- Ronald AlvarezNashville$33K
- Alaina BrownNashville$17K
- Lauren PrescottNashville$7K
- Aaron NizamNashville$5K
- Stephanie SullivanNashville$5K
- Courtney PennNashville$3K
- Laura WilliamsNashville$3K
- Mali SchneiterNashville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.